Sharekhan

3B BlackBio Dx Ltd

Fri 5/06/2026,12:9:44 | NSE : 3BBLACKBIO

₹ 1115.90-11.00 (-0.98%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1140.10

Previous Close

₹ 1126.90

Volume

2375

Mkt Cap ( Rs. Cr)

₹957.74

High

₹ 1149.00

Low

₹ 1110.00

52 Week High

₹ 1424.70

52 Week Low

₹ 1085.00

Book Value Per Share

₹ 373.63

Dividend Yield

0.44

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on 3B BlackBio Dx Ltd

Your Vote -

Buy

45.07%

Hold

50.70%

Sell

4.23%

45.07%

71 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

58%

Sell Order Quantity

42%

Bid Price

Qty

1115.50

3

1115.00

5

1115.00

100

1115.00

1

1115.00

30

Bid Total

2117

Bid Price

Qty

1118.70

1

1119.00

2

1119.00

1

1120.00

5

1120.00

1

Bid Total

1524

Option Chain

Analyzes market sentiment, predicts 3B BlackBio Dx Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • 3B BlackBio Dx - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    3 Jun 2026, 6:33PM Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and Financial Year ended March 31, 2026
  • 3B BlackBio Dx - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    1 Jun 2026, 6:25PM Audio Recording of Analysts/Investors Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31, 2026
  • 3B BlackBio Dx Q4 net profit down 19.37% at Rs 7.45 cr

    29 May 2026, 5:00PM The company reported standalone net profit of Rs 7.45 crore for the quarter ended March 31, 2026 as compared to Rs 9.24 crore in the same period last
  • 3B BlackBio Dx - Announcement under Regulation 30 (LODR)-Dividend Updates

    29 May 2026, 4:15PM Dividend Update
  • 3B BlackBio Dx - Announcement under Regulation 30 (LODR)-Investor Presentation

    29 May 2026, 4:13PM Investor's Presentation
  • 3B BlackBio Dx - Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended On 31St March, 2026

    29 May 2026, 3:58PM Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March, 2026
  • 3B BlackBio Dx - Board Meeting Outcome for Outcome Of Board Meeting

    29 May 2026, 3:43PM Outcome of Board Meeting held today i.e. 29th May, 2026
  • 3B BlackBio Dx - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 May 2026, 4:54PM Intimation of Earning Concall under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.
  • 3B BlackBio Dx - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consol

    20 May 2026, 3:28PM 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and a
  • 3B BlackBio Dx - Securities Of The Companies Permitted To Trade And Admitted To Dealings On The National Stock Exchange

    21 Apr 2026, 5:18PM Securities of the Companies permitted to trade and admitted to dealings on the National Stock Exchange
  • 3B BlackBio Dx - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    15 Apr 2026, 5:09PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • 3B BlackBio Dx - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    15 Apr 2026, 5:04PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • 3B BlackBio Dx - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    14 Apr 2026, 5:09PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • 3B BlackBio Dx has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    14 Apr 2026, 3:41PM As of March 2026, 40.94% is owned by Promoters and 59.06% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 38.46% and Fore
  • 3B BlackBio Dx - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Apr 2026, 5:41PM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
  • 3B BlackBio Dx - Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations, 2011

    4 Apr 2026, 4:19PM Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations, 2011
  • 3B BlackBio Dx - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    17 Mar 2026, 5:12PM Outcome of Schedule of Analyst/ Investor Meeting
  • 3B BlackBio Dx - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Mar 2026, 2:25PM Schedule of Analyst/ Investor Meeting

Key fundamentals

Evaluate the intrinsic value of 3B BlackBio Dx Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 319.0159 273.0929 228.4952 26.2492 26.4598
Liabilities 319.0159 273.0929 228.4952 26.2492 26.4598
Equity 8.5684 8.5684 8.5684 7.4918 7.4918
Gross Profit 53.1818 49.8559 35.1088 -0.9335 -1.2329
Net Profit 49.3169 47.5595 34.2135 2.1597 8.0073
Cash From Operating Activities 42.8207 44.4659 28.4663 1.6451 7.9762
NPM(%) 50.69 52.53 48.37 18 51.58
Revenue 97.275 90.5297 70.7245 11.9976 15.523
Expenses 44.0932 40.6738 35.6157 12.9311 16.7559
ROE(%) 15.37 14.83 10.66 0.67 2.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
5 50 0.45 1241.2

Peers

Other companies within the same industry or sector that are comparable to 3B BlackBio Dx Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1775.40 -2.47 16.58 1025.72 1071.07 0.00
Sharda Cropchem Ltd 894.10 -1.18 11.85 10192.66 754.66 1.68
Amines and Plasticizers Ltd 196.88 -2.77 29.65 6215.88 331.99 0.25
Indogulf Cropsciences Ltd 57.92 1.51 9.15 5511.71 63.31 0.00

Company Info

KILPEST INDIA LIMITED was incorporated as a Private Limited Company in the name of Kilpest Private Limited with Registrar of Companies, Madhya Pradesh at Gwalior on 27th May 1972 and was subsequently converted into a public limited company on 6th March, 1995. The Company is presently engaged in formulation of pesticides. The unit was initially set up as a Small Scale Unit with a single product, which has now grown into a medium scale units with multiproduct range. The unit has been running successfully throughout its working in the last two decades. The Company has an existing manufacturing capacity of liquid (2,00,000 Ltrs.) Dusting (2500 MT) and WDP (100 MT). The Company now proposes to expand its operation by way of expansion of its installed capacity and increase in product range alongwith backward integration. It propose to manufacture technical grade raw materials for captive consumption, which is basic raw material for downstream pesticide items. 2007 -Kilpest India has designated E-mail ID for Investor Complaints is is dkdkilpest@yahoo.co.in. 2011 -Kilpest india Ltd.launches Novel Biotech Indo-Spain JV project at Bhopal M.P. -Company has received an order for Rs. 7 Millions for supply of pesticide to be used in mosquito control program, from Dept. of Health & Family Welfare, Govt. of Orissa -The company launches Diagnostic Services 2012 -Kilpest india Ltd has received orders worth Rs. 13.00 millions for supply of pesticides to be used in mosquito control programme, from Department of Health & Family Welfare, Govt. of Odisha. -Company received orders worth Rs. 12.00 millions for supply of pesticides to be used in mosquito control programme, from Directorate of Health Services, Govt. of Madhya Pradesh. - Company has bagged an order worth Rs 6.71 million from Municipal Corporation of Delhi for supplying pesticides to be used in mosquito control programme. 2017 -Kilpest India arm bags award from FMPCCI, Bhopal. 2018 -Kilpest India arm bags MSME National Award 2018. 2023 -Company name has changed to 3B BlackBio Dx Ltd. from Kilpest India Ltd.

KILPEST INDIA LIMITED was incorporated as a Private Limited Company in the name of Kilpest Private Limited with Registrar of Companies, Madhya Pradesh at Gwalior on 27th May 1972 and was subsequently converted into a public limited company on 6th March, 1995. The Company is presently engaged in formulation of pesticides. The unit was initially set up as a Small Scale Unit with a single product, which has now grown into a medium scale units with multiproduct range. The unit has been running successfully throughout its working in the last two decades. The Company has an existing manufacturing capacity of liquid (2,00,000 Ltrs.) Dusting (2500 MT) and WDP (100 MT). The Company now proposes to expand its operation by way of expansion of its installed capacity and increase in product range alongwith backward integration. It propose to manufacture technical grade raw materials for captive consumption, which is basic raw material for downstream pesticide items. 2007 -Kilpest India has designated E-mail ID for Investor Complaints is is dkdkilpest@yahoo.co.in. 2011 -Kilpest india Ltd.launches Novel Biotech Indo-Spain JV project at Bhopal M.P. -Company has received an order for Rs. 7 Millions for supply of pesticide to be used in mosquito control program, from Dept. of Health & Family Welfare, Govt. of Orissa -The company launches Diagnostic Services 2012 -Kilpest india Ltd has received orders worth Rs. 13.00 millions for supply of pesticides to be used in mosquito control programme, from Department of Health & Family Welfare, Govt. of Odisha. -Company received orders worth Rs. 12.00 millions for supply of pesticides to be used in mosquito control programme, from Directorate of Health Services, Govt. of Madhya Pradesh. - Company has bagged an order worth Rs 6.71 million from Municipal Corporation of Delhi for supplying pesticides to be used in mosquito control programme. 2017 -Kilpest India arm bags award from FMPCCI, Bhopal. 2018 -Kilpest India arm bags MSME National Award 2018. 2023 -Company name has changed to 3B BlackBio Dx Ltd. from Kilpest India Ltd.

Read More

Parent Organisation

3B BlackBio Dx Ltd.

Founded

27/05/1972

Managing Director

Mr.Dhirendra Dubey

NSE Symbol

3BBLACKBIOEQ

FAQ

The current price of 3B BlackBio Dx Ltd is ₹ 1115.90.

The 52-week high for 3B BlackBio Dx Ltd is ₹ 1149.00 and the 52-week low is ₹ 1110.00.

The market capitalization of 3B BlackBio Dx Ltd is currently ₹ 957.74. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy 3B BlackBio Dx Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in 3B BlackBio Dx Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase 3B BlackBio Dx Ltd shares.

The CEO of 3B BlackBio Dx Ltd is Mr.Dhirendra Dubey, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT